Sanchez, Alvaro https://orcid.org/0000-0003-1163-9849
Pijoan, Jose I. https://orcid.org/0000-0002-5974-5280
Sainz de Rozas, Rita https://orcid.org/0000-0003-4416-1183
Lekue, Itxasne https://orcid.org/0009-0001-1812-6993
San Vicente, Ricardo
Quindimil, Jose Antonio https://orcid.org/0009-0002-2068-6903
Rotaeche, Rafael https://orcid.org/0000-0001-5594-3768
Etxeberria, Arritxu https://orcid.org/0000-0003-3563-2545
Mozo, Carmela https://orcid.org/0000-0003-3481-3328
Martinez-Cengotitabengoa, Monica https://orcid.org/0000-0003-3831-0541
Monge, Monica https://orcid.org/0000-0003-2306-961X
Gómez-Ramírez, Cristina https://orcid.org/0000-0001-8784-5783
Vivanco, Lourdes
Martin, Vanesa
Merino-Inda, Nerea https://orcid.org/0000-0002-5091-3428
Llarena, Marta https://orcid.org/0000-0001-9065-3694
Gonzalez Saenz de Tejada, Marta https://orcid.org/0000-0003-3826-6587
Garcia-Alvarez, Arturo https://orcid.org/0000-0001-8481-0104
Article History
Received: 10 November 2025
Accepted: 12 May 2026
First Online: 22 May 2026
Declarations
Ethics approval and consent to participate: The DE-imFAR research protocol was reviewed and approved by the Basque Country Clinical Research Ethics Committee (Reference: EOM2022018, approved on 30 March 2022) and was registered in the U.S. NLM ClinicalTrials.gov database (ClinicalTrials.gov Identifier NCT04022850. . Registered 17 July 2019; Last update 11 February 2025). The participants provided their written informed consent to participate in this study. The Primary Care Research Unit of Bizkaia is explicitly authorized by the Healthcare Directorate of Osakidetza—Basque Health Service to extract and use data from EHRs for research purposes.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.